HRP20060404A2 - New piperazine derivatives of dialkyl oxindoles - Google Patents
New piperazine derivatives of dialkyl oxindolesInfo
- Publication number
- HRP20060404A2 HRP20060404A2 HR20060404A HRP20060404A HRP20060404A2 HR P20060404 A2 HRP20060404 A2 HR P20060404A2 HR 20060404 A HR20060404 A HR 20060404A HR P20060404 A HRP20060404 A HR P20060404A HR P20060404 A2 HRP20060404 A2 HR P20060404A2
- Authority
- HR
- Croatia
- Prior art keywords
- oxindoles
- dialkyl
- piperazine derivatives
- new piperazine
- fraction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Polyurethanes Or Polyureas (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0400957A HU0400957D0 (en) | 2004-05-11 | 2004-05-11 | Piperazinbe derivatives of dialkyl oxindoles |
| HU0500464A HUP0500464A3 (en) | 2005-05-05 | 2005-05-05 | Piperazine derivatives of dialkyl-oxindoles |
| PCT/HU2005/000052 WO2005109987A2 (en) | 2004-05-11 | 2005-05-11 | 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20060404A2 true HRP20060404A2 (en) | 2007-04-30 |
Family
ID=89986001
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20060404A HRP20060404A2 (en) | 2004-05-11 | 2005-05-11 | New piperazine derivatives of dialkyl oxindoles |
| HR20090504T HRP20090504T1 (hr) | 2004-05-11 | 2005-05-11 | 3-(((4-fenil)-piperazin-1-il)-alkil)-3-alkil-1,3-dihidro-2h-indol-2-on derivati i srodni spojevi za tretiranje poremećaja središnjeg živčanog sustava |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090504T HRP20090504T1 (hr) | 2004-05-11 | 2005-05-11 | 3-(((4-fenil)-piperazin-1-il)-alkil)-3-alkil-1,3-dihidro-2h-indol-2-on derivati i srodni spojevi za tretiranje poremećaja središnjeg živčanog sustava |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7786129B2 (de) |
| EP (1) | EP1776339B1 (de) |
| JP (1) | JP2007537229A (de) |
| KR (1) | KR20070011594A (de) |
| AT (1) | ATE435204T1 (de) |
| AU (1) | AU2005244389B2 (de) |
| BG (1) | BG109771A (de) |
| CA (1) | CA2565514A1 (de) |
| CZ (1) | CZ2006777A3 (de) |
| DE (1) | DE602005015223D1 (de) |
| DK (1) | DK1776339T3 (de) |
| EA (1) | EA014236B1 (de) |
| ES (1) | ES2329388T3 (de) |
| HR (2) | HRP20060404A2 (de) |
| IL (1) | IL179029A (de) |
| MX (1) | MXPA06013069A (de) |
| NO (1) | NO20065659L (de) |
| NZ (1) | NZ551547A (de) |
| PL (1) | PL1776339T3 (de) |
| PT (1) | PT1776339E (de) |
| RS (1) | RS20060623A (de) |
| SI (1) | SI1776339T1 (de) |
| SK (1) | SK51072006A3 (de) |
| WO (1) | WO2005109987A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2727585A1 (de) | 2006-05-16 | 2014-05-07 | Takeda Pharmaceutical Company Limited | In-vivo Screening-Methode |
| EP2789338A3 (de) | 2007-11-15 | 2015-01-14 | Takeda Pharmaceutical Company Limited | Kondensiertes Pyridinderivat und seine Verwendung |
| HUP0900071A2 (en) * | 2009-02-06 | 2010-10-28 | Egis Gyogyszergyar Nyilvanosan | Optically active 3-[(phenyl-piperazin-1-yl)alkyl]-3-alkyl-oxindole derivatives influencing the central nervous system and pharmaceutical compositions containing them |
| US20210052600A1 (en) | 2017-12-27 | 2021-02-25 | Takeda Pharmaceutical Company Limited | Therapeutic agents for stress urinary incontinence and incotinence of feces |
| CN118561738B (zh) * | 2024-05-09 | 2026-03-17 | 南京工业大学 | 一种3-吲哚酮的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2635104B1 (fr) | 1988-08-03 | 1992-04-30 | Synthelabo | Derives d'indolone, leur preparation et leur application en therapeutique |
| GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
| WO1998008816A1 (en) * | 1996-08-26 | 1998-03-05 | Meiji Seika Kaisha, Ltd. | Oxindole derivatives and psychotropic drugs |
| NZ551542A (en) * | 2004-05-11 | 2010-06-25 | Egis Gyogyszergyar Nyrt | Piperazine derivatives of alkyl oxindoles |
| AU2005240844A1 (en) * | 2004-05-11 | 2005-11-17 | Egis Gyogyszergyar Nyrt. | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
-
2005
- 2005-05-11 DE DE602005015223T patent/DE602005015223D1/de not_active Expired - Lifetime
- 2005-05-11 US US11/596,473 patent/US7786129B2/en not_active Expired - Fee Related
- 2005-05-11 WO PCT/HU2005/000052 patent/WO2005109987A2/en not_active Ceased
- 2005-05-11 RS RSP-2006/0623A patent/RS20060623A/sr unknown
- 2005-05-11 CZ CZ20060777A patent/CZ2006777A3/cs unknown
- 2005-05-11 MX MXPA06013069A patent/MXPA06013069A/es active IP Right Grant
- 2005-05-11 HR HR20060404A patent/HRP20060404A2/xx not_active Application Discontinuation
- 2005-05-11 JP JP2007512537A patent/JP2007537229A/ja not_active Ceased
- 2005-05-11 HR HR20090504T patent/HRP20090504T1/hr unknown
- 2005-05-11 KR KR1020067026024A patent/KR20070011594A/ko not_active Ceased
- 2005-05-11 SI SI200530785T patent/SI1776339T1/sl unknown
- 2005-05-11 AT AT05779909T patent/ATE435204T1/de active
- 2005-05-11 DK DK05779909T patent/DK1776339T3/da active
- 2005-05-11 CA CA002565514A patent/CA2565514A1/en not_active Abandoned
- 2005-05-11 PL PL05779909T patent/PL1776339T3/pl unknown
- 2005-05-11 EP EP05779909A patent/EP1776339B1/de not_active Expired - Lifetime
- 2005-05-11 ES ES05779909T patent/ES2329388T3/es not_active Expired - Lifetime
- 2005-05-11 EA EA200602083A patent/EA014236B1/ru not_active IP Right Cessation
- 2005-05-11 NZ NZ551547A patent/NZ551547A/en unknown
- 2005-05-11 AU AU2005244389A patent/AU2005244389B2/en not_active Ceased
- 2005-05-11 PT PT05779909T patent/PT1776339E/pt unknown
- 2005-05-11 SK SK5107-2006A patent/SK51072006A3/sk not_active Application Discontinuation
-
2006
- 2006-11-02 IL IL179029A patent/IL179029A/en not_active IP Right Cessation
- 2006-12-06 NO NO20065659A patent/NO20065659L/no not_active Application Discontinuation
- 2006-12-11 BG BG109771A patent/BG109771A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RS20060623A (sr) | 2008-09-29 |
| DE602005015223D1 (de) | 2009-08-13 |
| JP2007537229A (ja) | 2007-12-20 |
| PT1776339E (pt) | 2009-09-16 |
| WO2005109987A3 (en) | 2006-05-04 |
| EA200602083A1 (ru) | 2007-06-29 |
| AU2005244389B2 (en) | 2011-09-01 |
| EP1776339B1 (de) | 2009-07-01 |
| MXPA06013069A (es) | 2007-03-30 |
| ATE435204T1 (de) | 2009-07-15 |
| EP1776339A2 (de) | 2007-04-25 |
| NZ551547A (en) | 2010-06-25 |
| SK51072006A3 (sk) | 2007-05-03 |
| CZ2006777A3 (cs) | 2007-03-14 |
| SI1776339T1 (sl) | 2009-12-31 |
| WO2005109987A2 (en) | 2005-11-24 |
| WO2005109987A9 (en) | 2007-03-29 |
| PL1776339T3 (pl) | 2009-12-31 |
| ES2329388T3 (es) | 2009-11-25 |
| CA2565514A1 (en) | 2005-11-24 |
| HRP20090504T1 (hr) | 2009-10-31 |
| IL179029A0 (en) | 2007-03-08 |
| US20070232619A1 (en) | 2007-10-04 |
| IL179029A (en) | 2011-11-30 |
| AU2005244389A1 (en) | 2005-11-24 |
| DK1776339T3 (da) | 2009-11-02 |
| KR20070011594A (ko) | 2007-01-24 |
| NO20065659L (no) | 2007-01-29 |
| BG109771A (bg) | 2008-05-30 |
| US7786129B2 (en) | 2010-08-31 |
| EA014236B1 (ru) | 2010-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110977T1 (el) | Υποκατεστημενα παραγωγα ινδολης για φαρμακευτικη συνθεση για θεραπεια ασθενειων του αναπνευστικου | |
| SG10201809390QA (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
| MEP53708A (en) | 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition | |
| CY1110965T1 (el) | Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου | |
| ATE502921T1 (de) | Substituierte indole | |
| SE0202241D0 (sv) | Novel Compounds | |
| CY1111070T1 (el) | Παραγωγα 2-αμινο-κουιναζολινης χρησιμα ως αναστολεις της β-σεκρετασης (bace) | |
| EA200601141A1 (ru) | Сульфонамидные производные для лечения заболеваний | |
| EA201070804A1 (ru) | (аза)индольное производное, замещенное по положению 5, содержащая его фармацевтическая композиция, промежуточные соединения и способ их получения | |
| MX2007011695A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| NO20081014L (no) | Sammensetninger | |
| ECSP088270A (es) | Derivados de (indol-3-il)-heterociclo como agonistas del receptor cannabinoide cb1 | |
| ATE396970T1 (de) | 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri | |
| ATE521609T1 (de) | Aminothiazolylpyrimidinderivate und ihre verwendung bei der behandlung von krebs | |
| MY157425A (en) | Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses | |
| MX2007011698A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| HRP20060404A2 (en) | New piperazine derivatives of dialkyl oxindoles | |
| EA200700400A1 (ru) | Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
| GB0407025D0 (en) | Novel compounds | |
| GB0519760D0 (en) | Novel compounds | |
| HRP20060403A2 (en) | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders | |
| HRP20060402A2 (hr) | Derivati piridina alkilnih oksindola kao 5-ht7 receptorski aktivni agensi | |
| HRP20060420A2 (en) | Piperazine derivatives of alkyl oxindoles | |
| DE60316299D1 (de) | Herstellung von milchsäurederivaten und ihre anwendung | |
| EA200501669A1 (ru) | Замещенные производные индолина и индола |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20100419 Year of fee payment: 6 |
|
| OBST | Application withdrawn |